Aug. 5 at 10:21 AM
The U.S. health-care diagnostics company
$IDXX reported Q2 results that beat expectations, sending shares higher by +27.49% on Monday at
$682.78. Idexx earned
$3.63 per share on revenue of
$1.11 billion. Analysts expected a profit of
$3.30 per share on revenue of
$1.07B. The stock is up +65.15% in 2025 & +45.47% y/y, with a market cap of
$54.91B.